Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clover Health Investments ( (CLOV) ) has shared an update.
On August 11, 2025, Clover Health Investments, Corp. addressed shareholder inquiries by publishing responses to frequently asked questions prior to its second quarter 2025 earnings announcement. The responses, which include insights from Co-Founder and Executive Chairman Vivek Garipalli, aim to enhance engagement with shareholders and are accessible on the company’s website.
The most recent analyst rating on (CLOV) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
Clover Health’s stock score is influenced by its ongoing financial challenges, despite positive developments in operational metrics and an encouraging earnings call. The financial performance remains a significant concern due to negative margins and revenue decline. Technical indicators signal potential weakness, while valuation remains unattractive due to losses. The company’s achievements in profitability and membership growth offer potential for future improvement.
To see Spark’s full report on CLOV stock, click here.
More about Clover Health Investments
Average Trading Volume: 9,311,716
Technical Sentiment Signal: Sell
Current Market Cap: $1.11B
See more data about CLOV stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money